MedTrace Logo

Prevalence of Traumatic Events and PTSD in Immigrant and Non-immigrant Patients With Psychotic Disorder

NCT04867447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2023-07-06

No results posted yet for this study

Summary

Higher rates of psychosis are described in migrant population. Likewise, this populations could suffer several adversities during migration process that could lead to higher exposure to traumatic events and higher rates of posttraumatic stress disorder (PTSD). There is a growing evidence that trauma is associated with psychosis onset.

The aim of this research is to study the association between psychosis and traumatic events exposure/PTSD in immigrant population. Our hypothesis is that the higher incidence of psychosis described in immigrant population is associated to higher trauma exposure.

A case-control observational study is performed. Patients who presented at least one psychotic episode are recruited from acute and chronic units at "Parc Salut Mar" (Barcelona). Estimated total sample is 196 individuals. Trauma exposure is assessed by validated trauma scales. Known factors associated with psychosis are controled during the statistic analysis.

Conditions

  • Psychotic Disorders
  • Psychological Trauma
  • Stress, Psychological
  • Cross-Cultural Comparison

Interventions

DIAGNOSTIC_TEST

Psychological trauma evaluation

Psychological trauma exposure is assessed by validated scales: * Childhood Trauma Questionnaire (CTQ) * Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) * Cumulative Trauma Scale. * The Holmes and Rahe Stress Scale. Other clinical scales used: * Positive and Negative Syndrome Scale (PANSS). * Dissociative Experiences Scale (DES) * Mini-Mental State Examination (MMSE).

Sponsors & Collaborators

  • Universitat Autonoma de Barcelona

    collaborator OTHER

  • Parc de Salut Mar

    lead OTHER

Principal Investigators

  • Amira Trabsa Biskri, MD · Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2023-03-01
Completion
2023-03-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04867447 on ClinicalTrials.gov